Xiao Qu

机构：Beijing Institute of Technology, University of Science and Technology of China, Anhui Medical University, Soochow University, Zhangjiagang First People's Hospital, First Affiliated Hospital of Anhui Medical University, First Hospital of China Medical University, China Medical University · ORCID：0000-0003-2990-062X

发表论文 79 篇 · 总被引 2715 次 · h-index 30

代表论文

• Fusobacterium Nucleatum Promotes the Development of Colorectal Cancer by Activating a Cytochrome P450/Epoxyoctadecenoic Acid Axis via TLR4/Keap1/NRF2 Signaling (2021 · Cancer Research · 被引 192)
• STK11 /LKB1 Mutations in NSCLC Are Associated with KEAP1/NRF2-Dependent Radiotherapy Resistance Targetable by Glutaminase Inhibition (2020 · Clinical Cancer Research · 被引 118)
• The Association of Post-Stroke Cognitive Impairment and Gut Microbiota and its Corresponding Metabolites (2020 · Journal of Alzheimer s Disease · 被引 101)
• Efficacy, safety, and biomarker analysis of Camrelizumab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma (CAPTAIN study) (2021 · Journal for ImmunoTherapy of Cancer · 被引 98)
• Modulation of Intratumoral Fusobacterium nucleatum to Enhance Sonodynamic Therapy for Colorectal Cancer with Reduced Phototoxic Skin Injury (2023 · ACS Nano · 被引 86)
• All’s well that ends (and peaks) well? A meta-analysis of the peak-end rule and duration neglect (2022 · Organizational Behavior and Human Decision Processes · 被引 58)